Development and validation of a screening tool for early identification of bloodstream infection in older patients – a retrospective case-control study
BMC Geriatrics Jan 10, 2020
Walker SAN, Bannerman H, Ma N, et al. - Given the occurrence of delayed diagnosis of bloodstream infection (BSI) in > 20% of older patients, with misdiagnosis in 35%, researchers intended to create as well as validate a clinically beneficial screening instrument to recognize older patients with a high chance of having a BSI. In this retrospective matched case-controlled study, an evaluation of hospitalized patients > 80 years old with BSI (n = 105/group) was performed to develop the tool. For validation, they used distinct retrospectively matched case and control patients > 80 years old (n = 120/group) and 65 to 79 years old (n = 250/group) (test cohort). In the learn and test cohorts, the favorable performance metrics of the optimal screening tool [Ln (odds of BSI) = − 150.299 + 3.751(Tmax: maximum temperature) + 0.654(neutrophils) + 0.452(change in LOC: level of consciousness) + 0.307(BUN: blood urea nitrogen) + 0.154(glucose) + 0.038(albumin) + 0.005(ALT: alanine aminotransferase)] were evident, and this tool outperformed the use of only temperature and neutrophil count. With a high predictive value, the validated tool may afford better early identification as well as treatment of BSI in older patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries